Clinical Trial Update: A Study of Gemcitabine, Capecitabine and Bevacizumab to Treat Cancer of the Gall Bladder or Bile Ducts [Phase 2]

View source ↗

Summary

Phase 2 study evaluating gemcitabine, capecitabine, and bevacizumab in cholangiocarcinoma (gallbladder and bile duct cancers); the trial has been completed with…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cholangiocarcinoma

Drugs mentioned

• Avastin (bevacizumab)
• Gemzar (gemcitabine)
• Xeloda (capecitabine)

Snippet

Sponsor: Roswell Park Cancer Institute | Conditions: Cholangiocarcinoma | Phase 2 | Status: COMPLETED | Results posted: 2017-03-29